7.4 Endophthalmitis, Post-Operative, (Exogenous Endophthalmitis)
Date of last review:
29/4/2026
Date of next review:
29/4/2028
Date of publication:
6/7//2026
Differential Diagnosis (1)
-
Endogenous endophthalmitis (due to haematological spread of various pathogens)
-
Postoperative sterile inflammation, e.g. from retained lens material
-
Toxic Anterior Segment Syndrome (TASS)
-
Other causes of acute red eye, for example acute anterior uveitis
-
Vitreous haemorrhage
Possible management by optometrist
Advice
-
No non-pharmacological treatment is recommended (1)
-
Following ophthalmic examination;
-
Clearly communicate the urgency of the condition (7)
-
Instruct the patient they are required to attend the hospital eye department (or A&E if no ophthalmology support available) immediately (7)
-
Treatment
-
No optometric treatment— emergency referral required (1)
-
Follow local protocols for same-day referral (7)
-
Typical adult dosage/duration
(Blue text = IP, black text = non-IP)
-
Not applicable for this condition (7)
Further management options
-
Emergency referral with no optometric intervention (1)
-
Explain to the patient that they must be seen urgently
-
Follow local protocols for same-day referral (7)
-
Ensure a clinician (in the receiving department) is informed the patient is attending (1)
-
Possible management in secondary care or local/community pathways where available
-
See Further management options (1,7)
-
Treatment initiated within one hour of diagnosis (1)
-
Hospital admission (1)
-
Ultrasound to assess vitreous involvement (if media is hazy) (1)
-
Anterior chamber/vitreous tap or vitrectomy, with microbiological testing (1)
-
Broad spectrum intravitreal antibiotics, e.g. (1):
-
Ceftazidime
-
Vancomycin
-
-
Adjunctive therapy (1):
-
Intravitreal corticosteroids
-
Oral antibiotics (case dependent)
-
-
Pars plana vitrectomy for severe or rapidly progressing cases (1)
College of Optometrists Clinical Management Guideline (1)
Endophthalmitis (post-operative) (exogenous endophthalmitis) - College of Optometrists *
* With special thanks to The College of Optometrists for providing the evidence framework for diagnosis and management from the Clinical Management Guidelines (CMGs) for this condition. All references to the College/CMGs are included where appropriate and form the basis of the Community Eyecare Guidelines.
Guidance is informed by the following sources
-
College of Optometrists Clinical Management Guidelines Clinical Management Guidelines - College of Optometrists
-
Advisory alignment with the College of Optometrists Formulary Optometrists' Formulary - College of Optometrists
-
Advisory alignment with the BNF BNF (British National Formulary) | NICE
-
Advisory alignment with the Summary Product Characteristics taken from the EMC Home - electronic medicines compendium (emc)
-
Advisory alignment with Scottish Health Board formularies (where a clear majority is present) *
-
Advisory alignment with expert consensus (CEGG), informed by sources 2-5 above
-
Advisory alignment with expert consensus (CEGG)
-
“Annex C of the Statement” https://www.eyes.nhs.scot/for-professionals/legislation/
* Scottish formularies should be available within the Prescribing section of your Health Board pages on the eyes.nhs.scot website. If unavailable, contact your local Health Board for further information; Health Boards landing page
If you have a query relating to this page, please email NSS.ComEyecareGuidelineGroup@nhs.scot